# Erythromycin

NDC: 69238-1471
Generic name: Erythromycin
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20190707

FDA application: ANDA210954

## Active ingredients

- ERYTHROMYCIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69238-1471"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69238-1471
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb641ed4-8093-4e15-9cb9-8921b1093d50